Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin
- PMID: 15507957
- DOI: 10.1016/j.ajog.2004.03.039
Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin
Abstract
Objective: The purpose of this study was to conduct pilot studies for large randomized controlled trials to compare low-molecular-weight heparin with placebo for antenatal thromboprophylaxis (trial 1), and for thromboprophylaxis after cesarean delivery (trial 2).
Study design: Multicenter randomized controlled trials (trial 1, 23 units; trial 2, 8 units) were conducted. Pregnant women at increased risk for thromboembolic disease were eligible for trial 1; women who underwent cesarean delivery were eligible for trial 2. The interventions were once daily injections of low-molecular-weight heparin or placebo. Primary outcomes were as follows: trial 1, confirmed symptomatic thromboembolic events and symptomatic osteoporotic fractures; trial 2, confirmed symptomatic thromboembolic events and wound complications.
Results: Sixteen women were recruited for trial 1; 1 woman in the placebo group had a symptomatic thromboembolic event. One hundred forty-one women were recruited for trial 2; 1 woman in the low molecular weight heparin group had a symptomatic thromboembolic event.
Conclusion: Poor recruitment indicates that large-scale trials using these designs would be difficult. Collection of data on the number of women that are eligible and the reasons for nonrecruitment in future trials of these interventions would allow a better understanding of the reasons for poor recruitment.
Similar articles
-
Bone density changes in women who receive thromboprophylaxis in pregnancy.Am J Obstet Gynecol. 2006 Oct;195(4):1109-13. doi: 10.1016/j.ajog.2006.06.080. Am J Obstet Gynecol. 2006. PMID: 17000242 Clinical Trial.
-
Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.Hum Fertil (Camb). 2008 Dec;11(4):246-53. doi: 10.1080/14647270801995431. Hum Fertil (Camb). 2008. PMID: 19085261 Clinical Trial.
-
Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.Am J Med. 2005 May;118(5):503-14. doi: 10.1016/j.amjmed.2004.12.009. Am J Med. 2005. PMID: 15866253 Review.
-
[Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].Med Klin (Munich). 2009 Jan 15;104(1):20-7. doi: 10.1007/s00063-009-1004-z. Epub 2009 Jan 14. Med Klin (Munich). 2009. PMID: 19142593 Clinical Trial. German.
-
Thromboprophylaxis in medical patients: focus on France.Semin Thromb Hemost. 2002 Aug;28 Suppl 3:51-5. doi: 10.1055/s-2002-34077. Semin Thromb Hemost. 2002. PMID: 12232825 Review.
Cited by
-
Heparin for pregnant women with acquired or inherited thrombophilias.Cochrane Database Syst Rev. 2003;2003(2):CD003580. doi: 10.1002/14651858.CD003580. Cochrane Database Syst Rev. 2003. PMID: 12804477 Free PMC article.
-
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0. J Thromb Thrombolysis. 2016. PMID: 26780741 Free PMC article.
-
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e691S-e736S. doi: 10.1378/chest.11-2300. Chest. 2012. PMID: 22315276 Free PMC article.
-
Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review.Front Cardiovasc Med. 2022 Apr 12;9:886416. doi: 10.3389/fcvm.2022.886416. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35498021 Free PMC article. Review.
-
Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.BMC Pregnancy Childbirth. 2012 May 30;12:40. doi: 10.1186/1471-2393-12-40. BMC Pregnancy Childbirth. 2012. PMID: 22646475 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical